Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.


BACKGROUND AND PURPOSE Little is known about informed consent for tissue plasminogen activator (tPA). Our objectives were to determine how frequently informed consent is obtained when tPA is given to stroke patients in clinical practice and whether the person providing consent (patient or surrogate) was the appropriate decision-maker. METHODS This… (More)


2 Figures and Tables